↓ Skip to main content

Aspirin and multiple sclerosis

Overview of attention for article published in BMC Medicine, June 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

twitter
35 X users
facebook
4 Facebook pages

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
94 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Aspirin and multiple sclerosis
Published in
BMC Medicine, June 2015
DOI 10.1186/s12916-015-0394-4
Pubmed ID
Authors

Sheila Tsau, Mitchell R. Emerson, Sharon G. Lynch, Steven M. LeVine

Abstract

Aspirin is widely used to lessen the risks of cardiovascular events. Some studies suggest that patients with multiple sclerosis have an increased risk for some cardiovascular events, for example, venous thromboembolism and perhaps ischemic strokes, raising the possibility that aspirin could lessen these increased risks in this population or subgroups (patients with limited mobility and/or antiphospholipid antibodies). However, aspirin causes a small increased risk of hemorrhagic stroke, which is a concern as it could potentially worsen a compromised blood-brain barrier. Aspirin has the potential to ameliorate the disease process in multiple sclerosis (for example, by limiting some components of inflammation), but aspirin also has the potential to inhibit mitochondrial complex I activity, which is already reduced in multiple sclerosis. In an experimental setting of a cerebral ischemic lesion, aspirin promoted the proliferation and/or differentiation of oligodendrocyte precursors, raising the possibility that aspirin could facilitate remyelination efforts in multiple sclerosis. Other actions by aspirin may lead to small improvements of some symptoms (for example, lessening fatigue). Here we consider potential benefits and risks of aspirin usage by patients with multiple sclerosis.

X Demographics

X Demographics

The data shown below were collected from the profiles of 35 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 94 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
Italy 1 1%
Unknown 92 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 16 17%
Student > Bachelor 11 12%
Student > Master 10 11%
Researcher 8 9%
Student > Doctoral Student 6 6%
Other 13 14%
Unknown 30 32%
Readers by discipline Count As %
Medicine and Dentistry 33 35%
Neuroscience 6 6%
Nursing and Health Professions 6 6%
Biochemistry, Genetics and Molecular Biology 5 5%
Agricultural and Biological Sciences 3 3%
Other 8 9%
Unknown 33 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 23. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 June 2018.
All research outputs
#1,586,568
of 25,085,910 outputs
Outputs from BMC Medicine
#1,119
of 3,922 outputs
Outputs of similar age
#19,305
of 269,072 outputs
Outputs of similar age from BMC Medicine
#23
of 70 outputs
Altmetric has tracked 25,085,910 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,922 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 45.6. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 269,072 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 70 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.